Cargando…
Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients—Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study
PURPOSE: Although cancer cachexia is mainly characterized by persistent loss of body weight (BW), usually in response to a malignancy, the pathophysiology of cachexia remains unresolved. To elucidate the relationship between the loss of BW and other related clinical factors, we conducted a nationwid...
Autores principales: | Takayama, Koichi, Atagi, Shinji, Imamura, Fumio, Tanaka, Hiroshi, Minato, Koichi, Harada, Toshiyuki, Katakami, Nobuyuki, Yokoyama, Takuma, Yoshimori, Kozo, Takiguchi, Yuichi, Hataji, Osamu, Takeda, Yuichiro, Aoe, Keisuke, Kim, Young Hak, Yokota, Soichiro, Tabeta, Hiroshi, Tomii, Keisuke, Ohashi, Yasuo, Eguchi, Kenji, Watanabe, Koshiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917580/ https://www.ncbi.nlm.nih.gov/pubmed/27003901 http://dx.doi.org/10.1007/s00520-016-3156-8 |
Ejemplares similares
-
Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial
por: Takayama, Koichi, et al.
Publicado: (2016) -
Anamorelin (ONO‐7643) for the treatment of patients with non–small cell lung cancer and cachexia: Results from a randomized, double‐blind, placebo‐controlled, multicenter study of Japanese patients (ONO‐7643‐04)
por: Katakami, Nobuyuki, et al.
Publicado: (2017) -
Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non‐small cell lung cancer
por: Hida, Toyoaki, et al.
Publicado: (2017) -
Multicentre phase II study of nivolumab in Japanese patients with advanced or recurrent non-squamous non-small cell lung cancer
por: Nishio, Makoto, et al.
Publicado: (2017) -
Three‐year follow‐up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non‐small cell lung cancer: Pooled analysis of ONO‐4538‐05 and ONO‐4538‐06 studies
por: Horinouchi, Hidehito, et al.
Publicado: (2019)